Lung Cancer Trial, Recruiting NCT07241182 Sponsor: Tri-Service General Hospital (TSGH) Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07241182
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with lung cancer, confirmed through tissue testing and imaging scans
  • People who are older than 18 years of age
  • People who have already received a type of chemotherapy that contains platinum
  • People whose doctors estimate they are expected to live for at least six months

Who may not be able to join:

  • People who would have difficulty taking a supplement on a consistent, timely schedule
  • People whose recent blood tests (taken within the past 14 days) show that the liver or kidneys are not functioning normally
  • People who have had an unexplained fever of 38.5°C or higher lasting 7 days in a row, or ongoing diarrhea lasting 15 days in a row, within the past 30 days
  • People who are currently receiving hormone therapy
  • People who have a significant heart condition or irregular heartbeat that the treating doctor considers serious enough to make trial participation unsuitable
  • People who have a significant nerve or nervous system disorder
  • People who currently have an active infection
  • People who have a known allergy or allergic reaction to the trial product or any of its ingredients
  • People who are currently taking any supplements that contain an extract from the fungus Antrodia camphorata

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-2-8792-3311

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tri-Service General Hospital (TSGH)
Registry
ClinicalTrials.gov
Start date
24 November 2025
Est. completion
31 March 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Nausea and vomiting; Sleep quality; Symptom assessment; Overall quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov